Skip to main content
. Author manuscript; available in PMC: 2020 Jun 3.
Published in final edited form as: J Pediatr. 2014 Jul 23;165(4):793–798. doi: 10.1016/j.jpeds.2014.05.053

Table II.

Unadjusted OR and aOR for putative risk factors for development of HA-VTE in noncritically ill children from univariate and multiple logistic regression

Putative risk factors Unadjusted Adjusted


OR 95% LCL 95% UCL P value OR 95% LCL 95% UCL P value
Age, y
 1–5 0.28 0.07 1.12 .07 0.38 0.05 2.75 .34
 6–10 1.57 0.58 4.23 .37 2.54 0.48 13.42 .27
 11–15 2.43 0.90 6.54 .08 2.21 0.40 12.32 .37
 16–21 1.99 0.76 5.19 .16 2.32 0.45 11.87 .31
CVC 31.49 13.97 71.02 <.001 27.67 8.40 91.22 <.0001
Infection 7.95 4.18 15.09 <.001 10.40 3.46 31.25 <.0001
Major surgery 0.20 0.06 0.66 .008 0.34 0.07 1.62 .17
Malignancy 5.06 2.58 9.94 <.001 0.90 0.31 2.62 .85
Obesity 4.40 1.02 19.03 .047 1.95 0.21 18.20 .56
Dehydration 1.51 0.59 3.84 .39
Chronic inflammatory disease (non-lupus) 7.67 2.14 27.52 .002 1.00 0.16 6.32 1.00
Hospital days (<4 vs ≥4) 15.38 6.37 37.14 <.001 5.26 1.74 15.88 .003
Previous hospitalization within 30 d 3.88 1.99 7.59 <.001 1.41 0.52 3.85 .50
Cardiac catheterization 14.54 1.29 163.41 .03 9.17 0.34 249.81 .19
History of prematurity 0.48 0.14 1.62 .24
Congenital heart disease 0.49 0.06 3.81 .5
Diabetes mellitus 1.17 0.14 9.93 .89
Cystic fibrosis 3.66 0.89 15.13 .07 0.92 0.12 6.93 .93

LCL, lower confidence limit; UCL, upper confidence limit.

Independent risk factors, as determined by the results of multivariate analysis, are shown in bold type.